Search results for

President Biden heads to Japan for the G7 summit. An appeals court case could remove abortion pills from the U.S. market completely. Ukraine says it's made advances in the battle for Bakhmut.

The PGA Tour has announced it's joining forces with Saudi-backed rival, LIV Golf. Since the announcement, the tour has come under fire for its decision.

Iran and Iranian-backed militias fired missiles at Israel and Arab states, apparently hitting the U.S. Embassy compound in Kuwait, while Israel and the United States pounded targets in Iran on Monday.

The Labor Department reports consumer prices data. The White House hosts a virtual global summit to discuss ransomware. The FDA allows a brand of e-cigarettes to stay on the market.

The Taliban still have no formal government in Afghanistan. Days after Hurricane Ida, rescue teams have difficulty reaching people. Texas Republicans pass a new bill restricting voting rights.

The country's top infectious disease doctor says he is looking for "a level of control" over COVID-19 such that it is less disruptive to society — and again stressed the importance of vaccination.

The White House waited to disclose a second meeting between President Trump and Vladimir Putin at the G-20. Also, tensions have increased outside a holy site in Jerusalem following a shooting.

Heated rhetoric continues to define Russia-Ukraine relations. A class-action lawsuit filed against the NFL and three teams alleges racism in hiring practices. Crude oil prices reach seven-year highs.

The Biden administration has delivered a plan to Russia offering a diplomatic way to resolve the crisis over Ukraine. NPR's Ari Shapiro talks with State Dept. spokesman Ned Price about the situation.

Merck documents show that in 2000, the maker of Vioxx tried to censor critics of the drug's safety. That was the year that drug giant Merck learned that Vioxx might cause heart attacks and other problems. The documents show a concerted effort by the company to identify doctors who were raising questions about the drug's safety and to put pressure on them to stop making critical comments. A spokesman for Merck denies the allegations.